Kenya Launches a Revised Malaria Strategy

MEASURE Evaluation PIMA (MEval-PIMA), in collaboration with the Kenya Ministry of Health (MOH), and World Health Organization (WHO), launched the Revised Kenya Malaria Strategy 2009–2018, and Kenya Malaria Monitoring and Evaluation Plan 2009–2018.

NAIROBI, KENYA, October 8, 2015—MEASURE Evaluation PIMA (MEval-PIMA), in collaboration with the Kenya Ministry of Health (MOH), and World Health Organization (WHO), launched the Revised Kenya Malaria Strategy 2009–2018, and Kenya Malaria Monitoring and Evaluation Plan 2009–2018.

: Dr. Custodia Mandlhate, WHO Country Representation, and Dr Elizabeth Ogaja, Kisumu County Chief Executive Committee member of Health (second from the right), celebrating the launch of the two documents.
Dr. Custodia Mandlhate, WHO Country Representation, and Dr Elizabeth Ogaja, Kisumu County Chief Executive Committee member of Health (second from the right), celebrating the launch of the two documents. The process of the development of the strategy and the plan involved consultation of all stakeholders, including the counties. Photo by Yvonne Otieno.
The Revised Kenya Malaria Strategy results from a mid-term review (2013-2014) of the National Malaria Strategy (NMS) 2009–2017. It is aligned to the Kenya Health Strategic and Investment plan (KHSSP) 2013–2018, the Kenya vision 2030, the Kenya Constitution 2010, the Millennium Development Goals, the Roll Back Malaria partnership goals, and the WHO guidelines.

The strategy was revised in response to policy and technical changes arising since 2009, which include the adoption and implementation of the 2010 Constitution, which called for the “devolution” of the health sector that transferred roles and responsibilities from the national to the county governments. In addition, new WHO technical guidance was issued that also required adaptation by member states.

The revised strategy recognized previous achievements, has suggested new approaches that acknowledge the important role of the private sector and the need for commodity security and strengthening health systems. With the revision of the strategy, it was also necessary to revise the Kenya Malaria Monitoring and Evaluation (M&E) Plan.

USAID-funded MEval-PIMA supports the Ministry of Health to deliver immediate results for the National Malaria Control Program (NMCP), through capacity building on M&E practices, trainings and workshops on M&E fundamentals, malaria surveillance, data analysis, and data management. As part of the support to the program, MEval-PIMA leads the review of the accompanying Kenya Malaria Monitoring and Evaluation Plan 2009–2018.

The Principal Secretary of Health Dr. Khadijah Kasaachoni gives a copy of the launched documents to MEASURE Evaluation PIMA Chief of Party, Edward Kunyanga
The Principal Secretary of Health Dr. Khadijah Kasaachoni gives a copy of the launched documents to MEASURE Evaluation PIMA Chief of Party, Edward Kunyanga. Photo by Yvonne Otieno.

The M&E plan is part of the implementation of the principle of the “three ones” in malaria control in Kenya: (1) one national malaria control coordinating authority where implementation is a country-led process; (2) one agreed-to comprehensive national plan for malaria control, including costed work plans; and (3) one agreed-to country-level M&E framework to serve the national malaria control program and its partners in effective monitoring of performance and outcomes. The plan articulates in detail indicators, sources of data, data collection and data analysis, and data use in evaluation of all program intervention areas. In addition, the plan addresses information reporting and feedback and the responsibilities of the various stakeholders in its implementation.

Learn more about MEval-PIMA support to the National Malaria Control Program.

For photos and quotes from the launch, see a PowerPoint presentation.

Access more information on the plan.

Filed under: Evaluation , Malaria , Kenya , MEASURE Evaluation PIMA
MailLinkedInTwitterFacebook
share this